Rape oil, oxidized

Basic toxicokinetics

Administrative data

Endpoint:

basic toxicokinetics, other

Type of information:

other: toxicokinetic assessment

Adequacy of study:

key study

Study period:

July 2010 - August 2010

Reliability:

2 (reliable with restrictions)

Rationale for reliability incl. deficiencies:

other: Toxicokinetic assessment by a certified toxicologist

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

2010

Report date:

2010

Materials and methods

Objective of study:

absorption

Test guideline

Test guideline 1

Qualifier:

according to guideline

Guideline:

other: Guidance on information requirements and chemical safety assessment Chapter R.7c: Endpoint specific guidance

Test guideline 2

Qualifier:

according to guideline

Guideline:

other: ECB EU Technical Guidance Document on Risk Assessment, 2003

GLP compliance:

yes (incl. QA statement)

Test material

Test material information

Constituent 1

Reference substance name:

Rape oil, oxidized

EC Number:

305-871-3

EC Name:

Rape oil, oxidized

Cas Number:

95193-59-2

Molecular formula:

Not applicable (a generic molecular formula cannot be provided for this specific UVCB substance).

IUPAC Name:

Oxidation products of seed oil obtained from Brassica napus, Brassicaceae (rapeseed)

Details on test material:

- Name of test material (as cited in study report): Blown rapeseed oil
- Substance type: Yellow to brown viscous liquid
- Physical state: liquid
- Analytical purity: treated as 100% pure
- Expiration date of the lot/batch: 16 December 2010
- Stability under test conditions: stable
- Storage condition of test material: At room temperature in the dark

Results and discussion

Main ADME results

Type:

absorption

Results:

For risk assessment purposes: oral absorption 50%, inhalation absorption 100% and dermal absorption 10%

Any other information on results incl. tables

TOXICOKINETIC ASSESSMENT

The water solubility of Blown rapeseed oil is very low (< 1 mg/L). Since in general a compound needs to be dissolved before it can be taken up from the gastro-intestinal tract, it is unlikely that Blown rapeseed oil will show a high systemic exposure after oral administration. However, its highly lipophilic character (log Pow > 6) indicates that uptake by micellular solubilisation may be of particular importance. For risk assessment purposes oral absorption of Blown rapeseed oil is set at 50%. The results of the toxicity studies do not provide reasons to deviate from this proposed oral absorption factor.

Once absorbed, distribution throughout the body will be limited due to its low water solubility. Intracellular concentration is expected to be higher than extracellular concentration based on its lipophilic character. Absorbed Blown rapeseed oil might undergo conjugation. The conjugates will either be excreted via the bile (high molecular weights compounds) or the urine (low molecular weight compounds).

Due to the very low vapour pressure (< 1.33 x 10-8 Pa) and the high boiling point (reaction and/or decomposition at ≥350°C) it is not to be expected that Blown rapeseed oil will reach the nasopharyncheal region or subsequently the tracheobranchial or pulmonary region. If Blown rapeseed oil reaches the tracheobranchial region it is likely that uptake of Blown rapeseed oil by crossing the alveolar and capillary membranes will take place based on its highly lipophilic character (log Po/w > 6). However, the low water solubility of Blown rapeseed oil (< 1 mg/L) indicates that absorption from the respiratory tract will be limited. Overall, although it is unlikely that Blown rapeseed oil will be available to a high extent after inhalation via the lungs, for risk assessment purposes the inhalation absorption of Blown rapeseed oil is set at 100%.

Blown rapeseed oil being a liquid has the potential to partition from the stratum corneum into the epidermis. However, the highly lipophilic character (log Po/w > 6) and the low water solubility (< 1 mg/L) of the substance indicate that the transfer between the stratum corneum and the epidermis will be impaired. Although the data are insufficient (no molecular weight available) to meet the criteria for 10% dermal absorption as given in the TGD, a dermal absorption of 10% is proposed for risk assessment purposes based on the available information. The results of the toxicity studies do not provide reasons to deviate from this proposed dermal absorption factor.

Applicant's summary and conclusion

Conclusions:

Interpretation of results (migrated information): other: the absorption factors for risk assessment purposes have been set by a certified toxicologist: oral absorption 50%, inhalation absorption 100% and dermal absorption 10%
For risk assessment purposes:
oral absorption: 50%
inhalation absorption: 100%
dermal absorption: 10%